Biosimilars in Belgium: a proposal for a more competitive market
Sign Up to like & getrecommendations! Published in 2020 at "Acta Clinica Belgica"
DOI: 10.1080/17843286.2020.1761690
Abstract: ABSTRACT More than ten years after the first biosimilars were authorized for use in the European Union, Belgium still experiences limited competition from biosimilars, as exemplified by low market shares. Achieving high biosimilar market shares… read more here.
Keywords: biologicals market; belgium proposal; proposal competitive; patent biologicals ... See more keywords
Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceuticals"
DOI: 10.3390/ph14060499
Abstract: Background: In Europe, off-patent biologicals and biosimilars are largely procured by means of tender procedures. The organization and design of tenders may play a key role in the evolving biosimilar market, and currently, it is… read more here.
Keywords: biologicals biosimilars; term; patent biologicals; market ... See more keywords